12/12
12:11 pm
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
12/12
12:11 pm
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
12/12
10:02 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/12
10:02 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/12
07:12 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
12/11
02:26 pm
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
12/11
02:26 pm
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
12/9
02:38 pm
gpcr
Rating for GPCR
Medium
Report
Rating for GPCR
12/9
02:38 pm
gpcr
Rating for GPCR
Medium
Report
Rating for GPCR
12/9
08:54 am
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
12/9
07:01 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
11/28
07:02 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/24
07:02 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..